Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients-Reference-Cited by-同舟云学术

Reasons and predictive factors for discontinuation of PDE-5 inhibitors despite successful intercourse in erectile dysfunction patients

Published:2013-12-05 Issue:3 Volume:26 Page:87-93
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Kim S-C,Lee Y-S,Seo K-K,Jung G-W,Kim T-H

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/ijir201341.pdf

Reference27 articles.

1. Balkrishnan R . Predictors of medication adherence in the elderly. Clin Therapeut 1988; 20: 764–771.

2. Porst H . Oral pharmacotherapy of erectile dysfunction. In: Porst H, Buvat J. the Standards Committee of the International Society for Sexual Medicine eds. Standard Practice in Sexual Medicine. Blackwell Publishing: Oxford pp 75–93 2006.

3. Gresser U, Gleiter CH . Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil—review of the literature. Eur J Med Res 2002; 7: 435–446.

4. Klotz T, Mathers M, Klotz R, Sommer F . Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)? Int J Impot Res 2005; 17: 2–4.

5. Jiann BP, Yu CC, Su CC, Tsai JY . Compliance of sildenafil treatment for erectile dysfunction and factors affecting it. Int J Impot Res 2006; 18: 146–149.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium;Sexual Medicine Reviews;2024-06-27

2. A Cost Analysis of Phosphodiesterase Type 5 Inhibitors in the United States;Urology;2024-01

3. The design, implementation, and impact of an automated patient-reported outcome data collection and adverse event surveillance tool: a randomized trial;BMC Health Services Research;2023-11-20

4. Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial;Journal of Urology;2023-07

5. A review on pharmacological options for the treatment of erectile dysfunction: state of the art and new strategies;Expert Opinion on Pharmacotherapy;2023-06-10